Clinical trial for Chronic Pain
Official title Virtual Reality for Pain and Well-Being in Older Adults
ClinicalTrials.gov ID: NCT07607899
What this study is testing
- What it's testing
- The study tests whether a virtual‑reality program can reduce fear of movement and improve confidence in older adults with chronic pain.
- Who it's for
- Adults 65 years or older who have chronic pain and a fear of movement.
- What's involved
- Participants in the experimental group will have up to eight 5‑30 minute virtual‑reality sessions, guided by a clinician, while the control group receives usual care. The VR sessions use calming or engaging environments and may involve gentle movement or motor imagery.
- Time commitment
- The study lasts about one month, with up to eight supervised VR sessions for the experimental group and no extra visits for the control group.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Age 65 years or older
- Able to understand and communicate in French
- Chronic pain lasting 6 months or longer
- Average pain intensity of 3 or greater on a 0-10 Numeric Rating Scale during the week prior to enrollment
- Score greater than 25 on the 11-item Tampa Scale of Kinesiophobia (TSK-11)
You likely can't join if
- Severe motion sickness or intolerance that would prevent safe use of a virtual reality headset (experimental group only)
- Medical condition that would prevent safe participation in rehabilitation activities
- Presence of open wounds or infection at painful or contralateral sites
See the full eligibility criteria
- Age 65 years or older
- Able to understand and communicate in French
- Chronic pain lasting 6 months or longer
- Average pain intensity of 3 or greater on a 0-10 Numeric Rating Scale during the week prior to enrollment
- Score greater than 25 on the 11-item Tampa Scale of Kinesiophobia (TSK-11)
- No neurocognitive impairment (Mini-Mental State Examination [MMSE] ≥ 24), or mild neurocognitive impairment (MMSE 18-24) with preserved capacity to consent (University of California Brief Assessment of Capacity to...
- Normal or corrected-to-normal visual acuity
- Severe motion sickness or intolerance that would prevent safe use of a virtual reality headset (experimental group only)
- Medical condition that would prevent safe participation in rehabilitation activities
- Presence of open wounds or infection at painful or contralateral sites
The study team makes the final eligibility decision.
Where it is enrolling
- Québec, Quebec, Canada
- Sainte-Marie, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Québec, Quebec, Canada; Sainte-Marie, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.